WILLIAM PATRICK FUSSELMAN MD NPI 1659356228

NPI Details

William Patrick Fusselman, MD is a hematology and oncology internal medicine in Cedar Rapids, IA with 31 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. William Patrick Fusselman, MD NPI is 1659356228. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE
Graduation Year:1995

The provider's business location address is:

202 10TH STREET SE
CEDAR RAPIDS, IA
ZIP 52403-404
Phone: (319) 297-2900
Fax: (319) 297-2969

The NPI 1659356228 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Magnesium level (HCPCS:83735)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Phosphate level (HCPCS:84100)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Unclassified drugs (HCPCS:J3490)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Extended patient service without direct patient contact, first hour (HCPCS:99358)
• Ct scan of chest without contrast (HCPCS:71250)
• Ct scan of chest with contrast (HCPCS:71260)
• Vitamin d-3 level (HCPCS:82306)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Limited x-ray of body bones (HCPCS:77074)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)

The enumeration date for this NPI number is 12/7/2005 and was last updated on 8/25/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.